{"uri":"bite-bystander-t-cell-dependent-cellular-cytotoxic-hwfb7bn","version_id":"0","protocol_name":"BiTE\u00ae bystander T cell-dependent cellular cytotoxicity (TDCC) assay","protocol_name_html":"BiTE\u00ae bystander T cell-dependent cellular cytotoxicity (TDCC) assay","is_prepublished":"0","can_edit":"0","parent_id":null,"api_version":"1","is_new_mode":"1","last_modified":"1522217461","type_id":"1","link":"https:\/\/doi.org\/10.1371\/journal.pone.0183390","fork_id":"","public_fork_note":"","number_of_steps":"5","has_versions":"1","first_published_date":"1495050015","publish_date":"2017-05-17 19:40:15","documents":null,"have_protocol_in_step":"0","is_protocol_in_step":"0","vendor_name":"Contributed by users","vendor_link":"https:\/\/www.protocols.io","vendor_logo":"\/img\/vendors\/1.png","mod_mins":"-45","mod_secs":"1","description":"<p>Protocol for detecting bystander cytotoxicity in mixed cultures of target-negative and target-positive cells treated with BiTE\u00ae antibody constructs. Two methods and one modification are described.<\/p>","is_bookmarked":"0","can_reassign":"1","before_start":"","has_guidelines":"0","materials":[],"warning":"","version_class":"5799","public":"1","is_owner":"1","is_original_owner":"1","created_on":"1494373710","protocol_affiliation":"Department of Oncology Research, Amgen Inc.","affiliation":null,"doi":"dx.doi.org\/10.17504\/protocols.io.hwfb7bn","doi_status":"2","changed_fork_steps":null,"profile_url":"x2y284w2t2","protocol_img":"https:\/\/www.protocols.io\/img\/default_protocol.png","profile_image":"\/img\/avatars\/006.png","full_name":"Sandra Ross","created_by":"Sandra Ross","private_link":"429CE67941061686AC0CF1D6C21C0AF3","original_img":"1","username":"sandra-ross","is_retracted":"0","retraction_reason":null,"plos_id":"10.1371\/journal.pone.0183390","manuscript_citation":"Ross SL,  Sherman M,  McElroy PL,  Lofgren JA,  Moody G,  Baeuerle PA,  Coxon A,  Arvedson T, Bispecific T cell engager (BiTE) antibody constructs can mediate bystander tumor cell killing. PLoS ONE  12(8). doi: <a target=\"_blank\" href=\"https:\/\/dx.doi.org\/10.1371\/journal.pone.0183390\">10.1371\/journal.pone.0183390<\/a> ","journal_name":"PLOS One","is_donations_disabled":"0","is_donations_disabled_by_user":"9","item_record_id":243355,"fork_info":[],"compare_forks":[],"protocols":[],"groups":[],"number_of_shared_runs":[],"ownership_history":[],"keywords":"","transfer_to_user":[],"sub_transfer":false,"is_transfer_pending":false,"number_of_bookmarks":"0","collections":[{"protocol_name":"Collection of protocols accompanying \"Bispecific T cell engager (BiTE\u00ae) antibody constructs can mediate bystander tumor cell killing\"","protocol_name_html":"Collection of protocols accompanying \"Bispecific T cell engager (BiTE\u00ae) antibody constructs can mediate bystander tumor cell killing\"","uri":"collection-of-protocols-accompanying-bispecific-t-ib8carw","username":"sandra-ross","profile_image":"\/img\/avatars\/006.png","protocol_img":"https:\/\/www.protocols.io\/img\/default_protocol.png","full_name":"Sandra Ross"}],"tags":[],"archived":0,"sub_authors":[],"sub_protocols_number":0,"can_edit_shared":0,"shared_runs":[],"is_shared_run":0,"is_shared":1,"banner":null,"contact_badges":[{"badge_id":"4","badge_image":"\/img\/badges\/gold.svg","badge_description":"Gold power author!"},{"badge_id":"5","badge_image":"\/img\/badges\/earlyadopter.svg","badge_description":"Early adopter"}],"number_of_comments":0,"is_locked":0,"is_locked_by":false,"authors":"Sandra L. Ross, Marika Sherman, Patricia L. McElroy, Julie A. Lofgren, Gordon Moody, Patrick A. Baeuerle, Angela Coxon, Tara Arvedson","authors_list":[{"name":"Sandra L. Ross","affiliation":"Department of Oncology Research, Amgen Inc.","username":null,"profile_image":null},{"name":" Marika Sherman","affiliation":"Department of Oncology Research, Amgen Inc.","username":null,"profile_image":null},{"name":" Patricia L. McElroy","affiliation":"Department of Oncology Research, Amgen Inc.","username":null,"profile_image":null},{"name":" Julie A. Lofgren","affiliation":"Department of Oncology Research, Amgen Inc.","username":null,"profile_image":null},{"name":" Gordon Moody","affiliation":"Department of Oncology Research, Amgen Inc.","username":null,"profile_image":null},{"name":" Patrick A. Baeuerle","affiliation":"Department of Oncology Research, Amgen Inc.","username":null,"profile_image":null},{"name":" Angela Coxon","affiliation":"Department of Oncology Research, Amgen Inc.","username":null,"profile_image":null},{"name":" Tara Arvedson","affiliation":"Department of Oncology Research, Amgen Inc.","username":null,"profile_image":null}],"user":{"profile_image":"\/img\/avatars\/006.png","username":"sandra-ross","full_name":"Sandra Ross","created_by":"Sandra Ross"},"access":{"can_view":"1","can_remove":"0","can_add":"0","can_edit":0,"can_publish":0,"can_get_doi":0,"can_share":"0","can_move":"1","can_transfer":"1","can_download":"1","is_locked":"0"},"is_contact_suspended":0,"guidelines":"","status_id":"1","is_research":"1","status_info":null,"steps":[{"id":"493511","is_changed":"0","original_id":"0","is_skipped":"0","is_checked":"0","guid":"2FAD99DA691143E7A046A894E3BF7BBA","previous_guid":null,"previous_id":"0","last_modified":"1494374142","components":[{"component_id":"797288","previous_id":0,"original_id":"0","guid":"7A688CAB7DE44842A0825C1E754978DF","previous_guid":null,"component_type_id":"1","data_id":"0","data":"<p>This assay is a modification of the standard TDCC assay (please refer to TDCC protocol). Target-positive and target-negative cells are mixed together in various ratios and the combined cells are used as the target cell population. At the end of the 48-hour incubation period, cytotoxicity is measured by one of two methods: (1) Cellular imaging - cells are stained with an antibody that detects the target (EGFR described here); cytotoxicity of target-positive and target-negative cells can thus be distinguished as populations below or above the target intensity threshold and each population is enumerated by counting nuclei; (2) Luciferase-labeled cells - target-negative cells expressing luciferase are generated using lentiviral transduction prior to mixing with target-positive cells; Steady-Glo\u00ae is then used to measure cytotoxicity of target-negative cells only.<\/p>\n<p>In a modification of the bystander assay, BiTE\u00ae-activated T cells are generated by mixing with target-positive cells and BiTE\u00ae for 24 hours. T cells are then transferred to target-negative cells.<\/p>","order_id":"0","name":"Description","data_by_id":"0","type_id":"1","source_data":{"description":"<p>This assay is a modification of the standard TDCC assay (please refer to TDCC protocol). Target-positive and target-negative cells are mixed together in various ratios and the combined cells are used as the target cell population. At the end of the 48-hour incubation period, cytotoxicity is measured by one of two methods: (1) Cellular imaging - cells are stained with an antibody that detects the target (EGFR described here); cytotoxicity of target-positive and target-negative cells can thus be distinguished as populations below or above the target intensity threshold and each population is enumerated by counting nuclei; (2) Luciferase-labeled cells - target-negative cells expressing luciferase are generated using lentiviral transduction prior to mixing with target-positive cells; Steady-Glo\u00ae is then used to measure cytotoxicity of target-negative cells only.<\/p>\n<p>In a modification of the bystander assay, BiTE\u00ae-activated T cells are generated by mixing with target-positive cells and BiTE\u00ae for 24 hours. T cells are then transferred to target-negative cells.<\/p>"},"is_project":0},{"component_id":"797286","previous_id":"797288","original_id":"0","guid":"0010A8A70B6545D7B37FD4CB2E4A4259","previous_guid":"7A688CAB7DE44842A0825C1E754978DF","component_type_id":"6","data_id":"0","data":"Overview","order_id":"1","name":"Section","data_by_id":"0","type_id":"6","source_data":{"section":"Overview"},"is_project":0}]},{"id":"493515","is_changed":"0","original_id":"0","is_skipped":"0","is_checked":"0","guid":"881C7EE884034648A8A774B80F00A50F","previous_guid":"2FAD99DA691143E7A046A894E3BF7BBA","previous_id":"493511","last_modified":"1494374184","components":[{"component_id":"797297","previous_id":0,"original_id":"0","guid":"D27DA9FC070941B4AE7F4E891ECF6F25","previous_guid":null,"component_type_id":"1","data_id":"0","data":"<table width=\"827\">\n<tbody>\n<tr>\n<td width=\"420\">\n<p><strong>Materials<\/strong><\/p>\n<\/td>\n<td width=\"251\">\n<p><strong>Company<\/strong><\/p>\n<\/td>\n<td width=\"156\">\n<p><strong>Cat.no.<\/strong><\/p>\n<\/td>\n<\/tr>\n<tr>\n<td width=\"420\">\n<p>Sterile 96-well clear V-bottom polypropylene plates<\/p>\n<\/td>\n<td width=\"251\">\n<p>Greiner<\/p>\n<\/td>\n<td width=\"156\">\n<p>651201<\/p>\n<\/td>\n<\/tr>\n<tr>\n<td width=\"420\">\n<p>Flat-bottom white 96-well plates (CellTiter-Glo\u00ae)<\/p>\n<\/td>\n<td width=\"251\">\n<p>Corning<\/p>\n<\/td>\n<td width=\"156\">\n<p>3917<\/p>\n<\/td>\n<\/tr>\n<tr>\n<td width=\"420\">\n<p>ViewPlate-96 black plate Packardview plate (imaging)<\/p>\n<\/td>\n<td width=\"251\">\n<p>Perkin Elmer<\/p>\n<\/td>\n<td width=\"156\">\n<p>6005182<\/p>\n<\/td>\n<\/tr>\n<tr>\n<td width=\"420\">\n<p>Flat-bottom white 384-well plates (Steady-Glo\u00ae)<\/p>\n<\/td>\n<td width=\"251\">\n<p>Corning<\/p>\n<\/td>\n<td width=\"156\">\n<p>3570<\/p>\n<\/td>\n<\/tr>\n<tr>\n<td width=\"420\">\n<p>Effector cells \u2013 unstimulated pan T cells<\/p>\n<\/td>\n<td width=\"251\">\n<p>AllCells<\/p>\n<\/td>\n<td width=\"156\">\n<p>PB009-1F<\/p>\n<\/td>\n<\/tr>\n<tr>\n<td width=\"420\">\n<p>Target cells \u2013 SW620, NUGC4, MOLM13<\/p>\n<\/td>\n<td width=\"251\">\n<p>Amgen cell bank<\/p>\n<\/td>\n<td width=\"156\">\n<p>-<\/p>\n<\/td>\n<\/tr>\n<tr>\n<td width=\"420\">\n<p>BiTE\u00aes \u2013 EGFR, MEC14, CD33<\/p>\n<\/td>\n<td width=\"251\">\n<p>Amgen<\/p>\n<\/td>\n<td width=\"156\">\n<p>-<\/p>\n<\/td>\n<\/tr>\n<tr>\n<td width=\"420\">\n<p>CellStripper\u2122 Dissociation Reagent nonenzymatic 1X<\/p>\n<\/td>\n<td width=\"251\">\n<p>Corning<\/p>\n<\/td>\n<td width=\"156\">\n<p>25056Cl<\/p>\n<\/td>\n<\/tr>\n<tr>\n<td width=\"420\">\n<p>1x PBS<\/p>\n<\/td>\n<td width=\"251\">\n<p>Gibco<\/p>\n<\/td>\n<td width=\"156\">\n<p>14190<\/p>\n<\/td>\n<\/tr>\n<tr>\n<td width=\"420\">\n<p>50 ml Falcon Tube<\/p>\n<\/td>\n<td width=\"251\">\n<p>BD<\/p>\n<\/td>\n<td width=\"156\">\n<p>35 2070<\/p>\n<\/td>\n<\/tr>\n<tr>\n<td width=\"420\">\n<p>15 ml Falcon Tube<\/p>\n<\/td>\n<td width=\"251\">\n<p>BD<\/p>\n<\/td>\n<td width=\"156\">\n<p>35 2096<\/p>\n<\/td>\n<\/tr>\n<tr>\n<td width=\"420\">\n<p>Growth medium: RPMI 1640 medium<\/p>\n<p>Supplements:<\/p>\n<p>100U\/ml penicillin\/streptomycin<\/p>\n<p>10% heat-inactivated fetal bovine serum (FBS)<\/p>\n<\/td>\n<td width=\"251\">\n<p>Gibco<\/p>\n<p>\u00a0<\/p>\n<p>Gibco<\/p>\n<p>Gibco<\/p>\n<\/td>\n<td width=\"156\">\n<p>11875-093<\/p>\n<p>\u00a0<\/p>\n<p>15140-122<\/p>\n<p>10082-147<\/p>\n<\/td>\n<\/tr>\n<tr>\n<td width=\"420\">\n<p>Assay medium: RPMI 1640 medium<\/p>\n<p>Supplements:<\/p>\n<p>1x nonessential amino acids (NEAA)<\/p>\n<p>10mM HEPES<\/p>\n<p>50\u00b5M 2-\u00df-mercaptoethanol<\/p>\n<p>1mM sodium pyruvate<\/p>\n<p>100U\/ml penicillin\/streptomycin<\/p>\n<p>5% heat-inactivated fetal bovine serum (FBS)<\/p>\n<\/td>\n<td width=\"251\">\n<p>Biochrom<\/p>\n<p>\u00a0<\/p>\n<p>Gibco<\/p>\n<p>Gibco<\/p>\n<p>Sigma<\/p>\n<p>Gibco<\/p>\n<p>Gibco<\/p>\n<p>Gibco<\/p>\n<\/td>\n<td width=\"156\">\n<p>FG1215<\/p>\n<p>\u00a0<\/p>\n<p>11140-050<\/p>\n<p>15630-080<\/p>\n<p>M6250<\/p>\n<p>11360-070<\/p>\n<p>15140-122<\/p>\n<p>10082-147<\/p>\n<\/td>\n<\/tr>\n<tr>\n<td width=\"420\">\n<p>Steady-Glo\u00ae Luciferase Assay System<\/p>\n<\/td>\n<td width=\"251\">\n<p>Promega<\/p>\n<\/td>\n<td width=\"156\">\n<p>E2510-10ml<\/p>\n<\/td>\n<\/tr>\n<tr>\n<td width=\"420\">\n<p>Hoechst 33342 nuclear dye<\/p>\n<\/td>\n<td width=\"251\">\n<p>ThermoFisher<\/p>\n<\/td>\n<td width=\"156\">\n<p>62249<\/p>\n<\/td>\n<\/tr>\n<tr>\n<td width=\"420\">\n<p>Formaldeyde 16% (w\/v) methanol-free<\/p>\n<\/td>\n<td width=\"251\">\n<p>Pierce\/ThermoFisher<\/p>\n<\/td>\n<td width=\"156\">\n<p>28908<\/p>\n<\/td>\n<\/tr>\n<tr>\n<td width=\"420\">\n<p>Mouse anti-human EGFR antibody (Clone 199.12)<\/p>\n<\/td>\n<td width=\"251\">\n<p>ThermoFisher<\/p>\n<\/td>\n<td width=\"156\">\n<p>MA5-13319<\/p>\n<\/td>\n<\/tr>\n<tr>\n<td width=\"420\">\n<p>Goat anti-mouse-AlexaFluor\u00ae 488<\/p>\n<\/td>\n<td width=\"251\">\n<p>ThermoFisher<\/p>\n<\/td>\n<td width=\"156\">\n<p>A-11029<\/p>\n<\/td>\n<\/tr>\n<tr>\n<td width=\"420\">\n<p>Normal goat serum<\/p>\n<\/td>\n<td width=\"251\">\n<p>Sigma<\/p>\n<\/td>\n<td width=\"156\">\n<p>G9023<\/p>\n<\/td>\n<\/tr>\n<\/tbody>\n<\/table>","order_id":"0","name":"Description","data_by_id":"0","type_id":"1","source_data":{"description":"<table width=\"827\">\n<tbody>\n<tr>\n<td width=\"420\">\n<p><strong>Materials<\/strong><\/p>\n<\/td>\n<td width=\"251\">\n<p><strong>Company<\/strong><\/p>\n<\/td>\n<td width=\"156\">\n<p><strong>Cat.no.<\/strong><\/p>\n<\/td>\n<\/tr>\n<tr>\n<td width=\"420\">\n<p>Sterile 96-well clear V-bottom polypropylene plates<\/p>\n<\/td>\n<td width=\"251\">\n<p>Greiner<\/p>\n<\/td>\n<td width=\"156\">\n<p>651201<\/p>\n<\/td>\n<\/tr>\n<tr>\n<td width=\"420\">\n<p>Flat-bottom white 96-well plates (CellTiter-Glo\u00ae)<\/p>\n<\/td>\n<td width=\"251\">\n<p>Corning<\/p>\n<\/td>\n<td width=\"156\">\n<p>3917<\/p>\n<\/td>\n<\/tr>\n<tr>\n<td width=\"420\">\n<p>ViewPlate-96 black plate Packardview plate (imaging)<\/p>\n<\/td>\n<td width=\"251\">\n<p>Perkin Elmer<\/p>\n<\/td>\n<td width=\"156\">\n<p>6005182<\/p>\n<\/td>\n<\/tr>\n<tr>\n<td width=\"420\">\n<p>Flat-bottom white 384-well plates (Steady-Glo\u00ae)<\/p>\n<\/td>\n<td width=\"251\">\n<p>Corning<\/p>\n<\/td>\n<td width=\"156\">\n<p>3570<\/p>\n<\/td>\n<\/tr>\n<tr>\n<td width=\"420\">\n<p>Effector cells \u2013 unstimulated pan T cells<\/p>\n<\/td>\n<td width=\"251\">\n<p>AllCells<\/p>\n<\/td>\n<td width=\"156\">\n<p>PB009-1F<\/p>\n<\/td>\n<\/tr>\n<tr>\n<td width=\"420\">\n<p>Target cells \u2013 SW620, NUGC4, MOLM13<\/p>\n<\/td>\n<td width=\"251\">\n<p>Amgen cell bank<\/p>\n<\/td>\n<td width=\"156\">\n<p>-<\/p>\n<\/td>\n<\/tr>\n<tr>\n<td width=\"420\">\n<p>BiTE\u00aes \u2013 EGFR, MEC14, CD33<\/p>\n<\/td>\n<td width=\"251\">\n<p>Amgen<\/p>\n<\/td>\n<td width=\"156\">\n<p>-<\/p>\n<\/td>\n<\/tr>\n<tr>\n<td width=\"420\">\n<p>CellStripper\u2122 Dissociation Reagent nonenzymatic 1X<\/p>\n<\/td>\n<td width=\"251\">\n<p>Corning<\/p>\n<\/td>\n<td width=\"156\">\n<p>25056Cl<\/p>\n<\/td>\n<\/tr>\n<tr>\n<td width=\"420\">\n<p>1x PBS<\/p>\n<\/td>\n<td width=\"251\">\n<p>Gibco<\/p>\n<\/td>\n<td width=\"156\">\n<p>14190<\/p>\n<\/td>\n<\/tr>\n<tr>\n<td width=\"420\">\n<p>50 ml Falcon Tube<\/p>\n<\/td>\n<td width=\"251\">\n<p>BD<\/p>\n<\/td>\n<td width=\"156\">\n<p>35 2070<\/p>\n<\/td>\n<\/tr>\n<tr>\n<td width=\"420\">\n<p>15 ml Falcon Tube<\/p>\n<\/td>\n<td width=\"251\">\n<p>BD<\/p>\n<\/td>\n<td width=\"156\">\n<p>35 2096<\/p>\n<\/td>\n<\/tr>\n<tr>\n<td width=\"420\">\n<p>Growth medium: RPMI 1640 medium<\/p>\n<p>Supplements:<\/p>\n<p>100U\/ml penicillin\/streptomycin<\/p>\n<p>10% heat-inactivated fetal bovine serum (FBS)<\/p>\n<\/td>\n<td width=\"251\">\n<p>Gibco<\/p>\n<p>\u00a0<\/p>\n<p>Gibco<\/p>\n<p>Gibco<\/p>\n<\/td>\n<td width=\"156\">\n<p>11875-093<\/p>\n<p>\u00a0<\/p>\n<p>15140-122<\/p>\n<p>10082-147<\/p>\n<\/td>\n<\/tr>\n<tr>\n<td width=\"420\">\n<p>Assay medium: RPMI 1640 medium<\/p>\n<p>Supplements:<\/p>\n<p>1x nonessential amino acids (NEAA)<\/p>\n<p>10mM HEPES<\/p>\n<p>50\u00b5M 2-\u00df-mercaptoethanol<\/p>\n<p>1mM sodium pyruvate<\/p>\n<p>100U\/ml penicillin\/streptomycin<\/p>\n<p>5% heat-inactivated fetal bovine serum (FBS)<\/p>\n<\/td>\n<td width=\"251\">\n<p>Biochrom<\/p>\n<p>\u00a0<\/p>\n<p>Gibco<\/p>\n<p>Gibco<\/p>\n<p>Sigma<\/p>\n<p>Gibco<\/p>\n<p>Gibco<\/p>\n<p>Gibco<\/p>\n<\/td>\n<td width=\"156\">\n<p>FG1215<\/p>\n<p>\u00a0<\/p>\n<p>11140-050<\/p>\n<p>15630-080<\/p>\n<p>M6250<\/p>\n<p>11360-070<\/p>\n<p>15140-122<\/p>\n<p>10082-147<\/p>\n<\/td>\n<\/tr>\n<tr>\n<td width=\"420\">\n<p>Steady-Glo\u00ae Luciferase Assay System<\/p>\n<\/td>\n<td width=\"251\">\n<p>Promega<\/p>\n<\/td>\n<td width=\"156\">\n<p>E2510-10ml<\/p>\n<\/td>\n<\/tr>\n<tr>\n<td width=\"420\">\n<p>Hoechst 33342 nuclear dye<\/p>\n<\/td>\n<td width=\"251\">\n<p>ThermoFisher<\/p>\n<\/td>\n<td width=\"156\">\n<p>62249<\/p>\n<\/td>\n<\/tr>\n<tr>\n<td width=\"420\">\n<p>Formaldeyde 16% (w\/v) methanol-free<\/p>\n<\/td>\n<td width=\"251\">\n<p>Pierce\/ThermoFisher<\/p>\n<\/td>\n<td width=\"156\">\n<p>28908<\/p>\n<\/td>\n<\/tr>\n<tr>\n<td width=\"420\">\n<p>Mouse anti-human EGFR antibody (Clone 199.12)<\/p>\n<\/td>\n<td width=\"251\">\n<p>ThermoFisher<\/p>\n<\/td>\n<td width=\"156\">\n<p>MA5-13319<\/p>\n<\/td>\n<\/tr>\n<tr>\n<td width=\"420\">\n<p>Goat anti-mouse-AlexaFluor\u00ae 488<\/p>\n<\/td>\n<td width=\"251\">\n<p>ThermoFisher<\/p>\n<\/td>\n<td width=\"156\">\n<p>A-11029<\/p>\n<\/td>\n<\/tr>\n<tr>\n<td width=\"420\">\n<p>Normal goat serum<\/p>\n<\/td>\n<td width=\"251\">\n<p>Sigma<\/p>\n<\/td>\n<td width=\"156\">\n<p>G9023<\/p>\n<\/td>\n<\/tr>\n<\/tbody>\n<\/table>"},"is_project":0},{"component_id":"797290","previous_id":"797297","original_id":"0","guid":"A2D0E1BBAB154CC7AFBA0533DE0913D5","previous_guid":"D27DA9FC070941B4AE7F4E891ECF6F25","component_type_id":"6","data_id":"0","data":"Assemble materials","order_id":"1","name":"Section","data_by_id":"0","type_id":"6","source_data":{"section":"Assemble materials"},"is_project":0}]},{"id":"493523","is_changed":"0","original_id":"0","is_skipped":"0","is_checked":"0","guid":"C36ED882E251433694748B2743F3418D","previous_guid":"881C7EE884034648A8A774B80F00A50F","previous_id":"493515","last_modified":"1494374269","components":[{"component_id":"797303","previous_id":0,"original_id":"0","guid":"5A0ECBAD069C428B9C17DB1655DC1A0E","previous_guid":null,"component_type_id":"1","data_id":"0","data":"<ul>\n<li>Follow TDCC assay protocol, substituting mixtures of EGFR<sup>+<\/sup> (e.g., NUGC4) and EGFR<sup>-<\/sup> (e.g., SW620) cells such that the total cell number is 10,000 cells\/well\n<ul>\n<li>Dilute EGFR+ and EGFR- cells to 200,000\/ml<\/li>\n<li>Mix together in ratios in 15ml conical tubes:\n<ul>\n<li>100% EGFR<sup>+<\/sup> = 6 ml EGFR<sup>+<\/sup> cells<\/li>\n<li>75% EGFR<sup>+ <\/sup>+ 25% EGFR<sup>-<\/sup> cells = 4.5 ml EGFR<sup>+ <\/sup>+ 1.5 ml EGFR<sup>-<\/sup> cells<\/li>\n<li>50% EGFR<sup>+ <\/sup>+ 50% EGFR<sup>-<\/sup> cells = 3 ml EGFR<sup>+ <\/sup>+ 3 ml EGFR<sup>-<\/sup> cells<\/li>\n<li>25% EGFR<sup>+ <\/sup>+ 75% EGFR<sup>-<\/sup> cells = 1.5 ml EGFR<sup>+ <\/sup>+ 4.5 ml EGFR<sup>-<\/sup> cells<\/li>\n<li>100% EGFR<sup>-<\/sup> cells = 6 ml EGFR<sup>-<\/sup> cells<\/li>\n<\/ul>\n<\/li>\n<li>Dispense 50 \u00b5l\/well of each cell mixture as target cells in TDCC protocol (10,000 total target cells\/well)\n<ul>\n<li>100% EGFR<sup>+<\/sup> = 10,000 EGFR<sup>+<\/sup> cells\/well<\/li>\n<li>75% EGFR<sup>+ <\/sup>+ 25% EGFR<sup>-<\/sup> cells = 7,500 EGFR<sup>+ <\/sup>+ 2,500 EGFR<sup>-<\/sup> cells\/well<\/li>\n<li>50% EGFR<sup>+ <\/sup>+ 50% EGFR<sup>-<\/sup> cells = 5,000 EGFR<sup>+ <\/sup>+ 5,000 EGFR<sup>-<\/sup> cells\/well<\/li>\n<li>25% EGFR<sup>+ <\/sup>+ 75% EGFR<sup>-<\/sup> cells = 2,500 EGFR<sup>+ <\/sup>+ 7,500 EGFR<sup>-<\/sup> cells\/well<\/li>\n<li>100% EGFR<sup>-<\/sup> cells = 10,000 EGFR<sup>-<\/sup> cells\/well<\/li>\n<\/ul>\n<\/li>\n<li>Assemble the TDCC assay as described in the TDCC protocol using black, clear-bottom PackardView plates, incubate 48 hours at 37\u00b0C.<\/li>\n<li>Wash and fix cells: Wash cells two times with PBS, and fix with formaldehyde as described in the TDCC imaging assay protocol.<\/li>\n<li>Prepare reagents while cells are fixing\n<ul>\n<li>Wash buffer: PBS + 5% normal goat serum<\/li>\n<li>Primary antibody (anti-EGFR): 1 \u00b5g\/ml in wash buffer<\/li>\n<li>Secondary antibody (goat anti-mouse-AlexaFluor\u00ae 488) + Hoechst nuclear dye: 5 \u00b5g\/ml secondary antibody + 5 \u00b5g\/ml Hoechst in wash buffer<\/li>\n<\/ul>\n<\/li>\n<li>After cells are fixed, wash two times with PBS<\/li>\n<li>Remove PBS and add 50 \u00b5l\/well primary antibody solution; incubate 1 hour at room temp.<\/li>\n<li>Remove primary antibody solution and wash 2X with 100 \u00b5l\/well wash buffer<\/li>\n<li>Remove wash buffer and add 50 \u00b5l\/well secondary antibody + Hoechst nuclear dye solution; incubate 1 hour at room temp. in the dark<\/li>\n<li>Remove secondary antibody\/Hoechst solution and wash 1X with 100 \u00b5l\/well wash buffer<\/li>\n<li>Remove wash buffer and wash 1X with 100 \u00b5l\/well PBS<\/li>\n<li>Remove PBS wash and add back 100 \u00b5l\/well PBS<\/li>\n<li>Seal plates and scan on ArrayScan\u2122 using Target Activation bioapplication\n<ul>\n<li>Control wells containing EGFR<sup>+ <\/sup>cells alone and EGFR<sup>-<\/sup> cells alone are used to set a threshold for AlexaFluor\u00ae 488 (EGFR) intensity such that &gt;95% of EGFR<sup>-<\/sup> cells are classified as negative and &gt;95% of EGFR<sup>+<\/sup> cells are classified as positive (see below).<\/li>\n<li>The ArrayScan\u2122 Target Activation bioapplication allows for classifying cells as \u201cType 1\u201d and \u201cType 2\u201d based on the average intensity in the EGFR channel (Channel 2). All nuclei are counted (Channel 1, Hoechst), and total nuclei in 16 10X fields are classified as Type 1 (below intensity threshold = EGFR<sup>-<\/sup>) or Type 2 (above intensity threshold = EGFR<sup>+<\/sup>).<\/li>\n<li>Note: Any remaining T cells left in wells after washes are excluded from cell counts by the lower nuclear size threshold.<\/li>\n<\/ul>\n<\/li>\n<\/ul>\n<\/li>\n<\/ul>","order_id":"0","name":"Description","data_by_id":"0","type_id":"1","source_data":{"description":"<ul>\n<li>Follow TDCC assay protocol, substituting mixtures of EGFR<sup>+<\/sup> (e.g., NUGC4) and EGFR<sup>-<\/sup> (e.g., SW620) cells such that the total cell number is 10,000 cells\/well\n<ul>\n<li>Dilute EGFR+ and EGFR- cells to 200,000\/ml<\/li>\n<li>Mix together in ratios in 15ml conical tubes:\n<ul>\n<li>100% EGFR<sup>+<\/sup> = 6 ml EGFR<sup>+<\/sup> cells<\/li>\n<li>75% EGFR<sup>+ <\/sup>+ 25% EGFR<sup>-<\/sup> cells = 4.5 ml EGFR<sup>+ <\/sup>+ 1.5 ml EGFR<sup>-<\/sup> cells<\/li>\n<li>50% EGFR<sup>+ <\/sup>+ 50% EGFR<sup>-<\/sup> cells = 3 ml EGFR<sup>+ <\/sup>+ 3 ml EGFR<sup>-<\/sup> cells<\/li>\n<li>25% EGFR<sup>+ <\/sup>+ 75% EGFR<sup>-<\/sup> cells = 1.5 ml EGFR<sup>+ <\/sup>+ 4.5 ml EGFR<sup>-<\/sup> cells<\/li>\n<li>100% EGFR<sup>-<\/sup> cells = 6 ml EGFR<sup>-<\/sup> cells<\/li>\n<\/ul>\n<\/li>\n<li>Dispense 50 \u00b5l\/well of each cell mixture as target cells in TDCC protocol (10,000 total target cells\/well)\n<ul>\n<li>100% EGFR<sup>+<\/sup> = 10,000 EGFR<sup>+<\/sup> cells\/well<\/li>\n<li>75% EGFR<sup>+ <\/sup>+ 25% EGFR<sup>-<\/sup> cells = 7,500 EGFR<sup>+ <\/sup>+ 2,500 EGFR<sup>-<\/sup> cells\/well<\/li>\n<li>50% EGFR<sup>+ <\/sup>+ 50% EGFR<sup>-<\/sup> cells = 5,000 EGFR<sup>+ <\/sup>+ 5,000 EGFR<sup>-<\/sup> cells\/well<\/li>\n<li>25% EGFR<sup>+ <\/sup>+ 75% EGFR<sup>-<\/sup> cells = 2,500 EGFR<sup>+ <\/sup>+ 7,500 EGFR<sup>-<\/sup> cells\/well<\/li>\n<li>100% EGFR<sup>-<\/sup> cells = 10,000 EGFR<sup>-<\/sup> cells\/well<\/li>\n<\/ul>\n<\/li>\n<li>Assemble the TDCC assay as described in the TDCC protocol using black, clear-bottom PackardView plates, incubate 48 hours at 37\u00b0C.<\/li>\n<li>Wash and fix cells: Wash cells two times with PBS, and fix with formaldehyde as described in the TDCC imaging assay protocol.<\/li>\n<li>Prepare reagents while cells are fixing\n<ul>\n<li>Wash buffer: PBS + 5% normal goat serum<\/li>\n<li>Primary antibody (anti-EGFR): 1 \u00b5g\/ml in wash buffer<\/li>\n<li>Secondary antibody (goat anti-mouse-AlexaFluor\u00ae 488) + Hoechst nuclear dye: 5 \u00b5g\/ml secondary antibody + 5 \u00b5g\/ml Hoechst in wash buffer<\/li>\n<\/ul>\n<\/li>\n<li>After cells are fixed, wash two times with PBS<\/li>\n<li>Remove PBS and add 50 \u00b5l\/well primary antibody solution; incubate 1 hour at room temp.<\/li>\n<li>Remove primary antibody solution and wash 2X with 100 \u00b5l\/well wash buffer<\/li>\n<li>Remove wash buffer and add 50 \u00b5l\/well secondary antibody + Hoechst nuclear dye solution; incubate 1 hour at room temp. in the dark<\/li>\n<li>Remove secondary antibody\/Hoechst solution and wash 1X with 100 \u00b5l\/well wash buffer<\/li>\n<li>Remove wash buffer and wash 1X with 100 \u00b5l\/well PBS<\/li>\n<li>Remove PBS wash and add back 100 \u00b5l\/well PBS<\/li>\n<li>Seal plates and scan on ArrayScan\u2122 using Target Activation bioapplication\n<ul>\n<li>Control wells containing EGFR<sup>+ <\/sup>cells alone and EGFR<sup>-<\/sup> cells alone are used to set a threshold for AlexaFluor\u00ae 488 (EGFR) intensity such that &gt;95% of EGFR<sup>-<\/sup> cells are classified as negative and &gt;95% of EGFR<sup>+<\/sup> cells are classified as positive (see below).<\/li>\n<li>The ArrayScan\u2122 Target Activation bioapplication allows for classifying cells as \u201cType 1\u201d and \u201cType 2\u201d based on the average intensity in the EGFR channel (Channel 2). All nuclei are counted (Channel 1, Hoechst), and total nuclei in 16 10X fields are classified as Type 1 (below intensity threshold = EGFR<sup>-<\/sup>) or Type 2 (above intensity threshold = EGFR<sup>+<\/sup>).<\/li>\n<li>Note: Any remaining T cells left in wells after washes are excluded from cell counts by the lower nuclear size threshold.<\/li>\n<\/ul>\n<\/li>\n<\/ul>\n<\/li>\n<\/ul>"},"is_project":0},{"component_id":"797299","previous_id":"797303","original_id":"0","guid":"B58535911B2D43CBA15D92417A98CD0D","previous_guid":"5A0ECBAD069C428B9C17DB1655DC1A0E","component_type_id":"6","data_id":"0","data":"EGFR bystander imaging TDCC assay","order_id":"1","name":"Section","data_by_id":"0","type_id":"6","source_data":{"section":"EGFR bystander imaging TDCC assay"},"is_project":0}]},{"id":"493528","is_changed":"0","original_id":"0","is_skipped":"0","is_checked":"0","guid":"A0C04A9C640142CFB0FD9E58C484470E","previous_guid":"C36ED882E251433694748B2743F3418D","previous_id":"493523","last_modified":"1494442055","components":[{"component_id":"797308","previous_id":0,"original_id":"0","guid":"D95412755C5948FAAAFE78EB647DA19A","previous_guid":null,"component_type_id":"1","data_id":"0","data":"<ul>\n<li>Use Corning 384-well plates for higher capacity and larger dose-response curves.<\/li>\n<li>Number of wells needed for each assay should be carefully calculated, depending on the number of cell lines, number of BiTE\u00ae antibody constructs, number of BiTE\u00ae dilutions, E:T ratios, controls and number of replicates.<\/li>\n<li>For 384-well plate assays, each well contains a final volume of 50 \u00b5l (5 \u00b5l 10X BiTE\u00ae dilutions), 25 \u00b5l T cells at desired E:T ratio and 20 \u00b5l target cells.<\/li>\n<li>In a typical 384-well assay, each well contains:\n<ul>\n<li>2,500 target cells<\/li>\n<li>25,000 T cells\/ well (10:1 E:T ratio)<\/li>\n<li>BiTE\u00ae dilutions starting at 1 nM final<\/li>\n<li>2 columns of control wells (one with target cells, T cells and no BiTE\u00ae and the other with target cells only)<\/li>\n<\/ul>\n<\/li>\n<li>For 384-well plates, liquid handling automation is used to dilute and dispense BiTE\u00ae (Bravo) and to dispense target cells and T cells (Multidrop)<\/li>\n<li>All steps are done in Biosafety laminar flow hood.<\/li>\n<li>Thaw T cells as described in TDCC protocol.<\/li>\n<li>Prepare target cells as described in TDCC protocol, except that cell density is 125,000 cells\/ml (125,000 cells\/ml X 0.02 ml = 2500 cells\/well).\n<ul>\n<li>For the EGFR<sup>-<\/sup> AML suspension cell line, cells are counted, centrifuged at 300 x g for 10 min and resuspended in fresh Assay Medium, then recounted before making the dilution.<\/li>\n<li>Mix together in EGFR<sup>+<\/sup> and EGFR<sup>-<\/sup> cell lines in ratios in 15ml conical tubes (10 ml total target cells + dead volume needed per 384-well plate):\n<ul>\n<li>100% EGFR<sup>+<\/sup> = 10 ml EGFR<sup>+<\/sup> cells<\/li>\n<li>75% EGFR<sup>+ <\/sup>+ 25% EGFR<sup>-<\/sup> cells = 7.5 ml EGFR<sup>+ <\/sup>+ 2.5 ml EGFR<sup>-<\/sup> cells<\/li>\n<li>50% EGFR<sup>+ <\/sup>+ 50% EGFR<sup>-<\/sup> cells = 5 ml EGFR<sup>+ <\/sup>+ 5 ml EGFR<sup>-<\/sup> cells<\/li>\n<li>25% EGFR<sup>+ <\/sup>+ 75% EGFR<sup>-<\/sup> cells = 2.5 ml EGFR<sup>+ <\/sup>+ 7.5 ml EGFR<sup>-<\/sup> cells<\/li>\n<\/ul>\n<\/li>\n<li>100% EGFR<sup>-<\/sup> cells = 10 ml EGFR<sup>-<\/sup> cells<\/li>\n<\/ul>\n<\/li>\n<li>Prepare BiTE\u00ae serial dilution plates (EGFR test BiTE\u00ae and CD33 positive control BiTE\u00ae for AML cell line)\n<ul>\n<li>22 dilutions + 1 column with target cells, T cells and no BiTE\u00ae and one column with target cells only)<\/li>\n<li>Starting 10X concentration is 10nM; serial dilutions in Assay Medium 2-fold across plate X 22 wells\n<ul>\n<li>Dispense 50 \u00b5l 10nM BiTE\u00ae into col. 1 and 25 \u00b5l Assay Medium into cols. 2-24<\/li>\n<li>Transfer 25 \u00b5l from col. 1 into col. 2, and so on across plate through col. 22)<\/li>\n<\/ul>\n<\/li>\n<li>Prepare T cells as described in TDCC protocol, except that cell density is 1x10e6 cells\/ml (1x10e6 cells\/ml X 0.025 ml = 25,000 cells\/well); 10 ml + dead volume needed per 384-well plate.<\/li>\n<li>Dispense 20 \u00b5l target cells and 25 \u00b5l T cells into assay plates (Multidrop); add 5 \u00b5l BiTE dilutions into assay plates (Bravo); mix 3 times with slow aspirate (Bravo).<\/li>\n<li>Leave assay plates at room temperature in hood for 30 min. before placing in tissue culture incubator.<\/li>\n<li>Incubate at 37\u00b0C for 48 hours.<\/li>\n<li>Steady-Glo\u00ae assay:\n<ul>\n<li>Thaw Steady-Glo\u00ae reagent to room temperature and reconstitute (10 ml needed per plate)<\/li>\n<li>Add 25 \u00b5l\/well of room temperature Steady-Glo\u00ae (Multidrop)<\/li>\n<li>Incubate 30 min. at room temperature<\/li>\n<li>Read on luminometer (EnVision with Ultrasensitive Lumi PMT)<\/li>\n<li>Analysis: Only EGFR<sup>-<\/sup> cells are labelled, so the luminescence readout is a direct count of EGFR<sup>-<\/sup> cytotoxicity<\/li>\n<\/ul>\n<\/li>\n<\/ul>\n<\/li>\n<\/ul>","order_id":"0","name":"Description","data_by_id":"0","type_id":"1","source_data":{"description":"<ul>\n<li>Use Corning 384-well plates for higher capacity and larger dose-response curves.<\/li>\n<li>Number of wells needed for each assay should be carefully calculated, depending on the number of cell lines, number of BiTE\u00ae antibody constructs, number of BiTE\u00ae dilutions, E:T ratios, controls and number of replicates.<\/li>\n<li>For 384-well plate assays, each well contains a final volume of 50 \u00b5l (5 \u00b5l 10X BiTE\u00ae dilutions), 25 \u00b5l T cells at desired E:T ratio and 20 \u00b5l target cells.<\/li>\n<li>In a typical 384-well assay, each well contains:\n<ul>\n<li>2,500 target cells<\/li>\n<li>25,000 T cells\/ well (10:1 E:T ratio)<\/li>\n<li>BiTE\u00ae dilutions starting at 1 nM final<\/li>\n<li>2 columns of control wells (one with target cells, T cells and no BiTE\u00ae and the other with target cells only)<\/li>\n<\/ul>\n<\/li>\n<li>For 384-well plates, liquid handling automation is used to dilute and dispense BiTE\u00ae (Bravo) and to dispense target cells and T cells (Multidrop)<\/li>\n<li>All steps are done in Biosafety laminar flow hood.<\/li>\n<li>Thaw T cells as described in TDCC protocol.<\/li>\n<li>Prepare target cells as described in TDCC protocol, except that cell density is 125,000 cells\/ml (125,000 cells\/ml X 0.02 ml = 2500 cells\/well).\n<ul>\n<li>For the EGFR<sup>-<\/sup> AML suspension cell line, cells are counted, centrifuged at 300 x g for 10 min and resuspended in fresh Assay Medium, then recounted before making the dilution.<\/li>\n<li>Mix together in EGFR<sup>+<\/sup> and EGFR<sup>-<\/sup> cell lines in ratios in 15ml conical tubes (10 ml total target cells + dead volume needed per 384-well plate):\n<ul>\n<li>100% EGFR<sup>+<\/sup> = 10 ml EGFR<sup>+<\/sup> cells<\/li>\n<li>75% EGFR<sup>+ <\/sup>+ 25% EGFR<sup>-<\/sup> cells = 7.5 ml EGFR<sup>+ <\/sup>+ 2.5 ml EGFR<sup>-<\/sup> cells<\/li>\n<li>50% EGFR<sup>+ <\/sup>+ 50% EGFR<sup>-<\/sup> cells = 5 ml EGFR<sup>+ <\/sup>+ 5 ml EGFR<sup>-<\/sup> cells<\/li>\n<li>25% EGFR<sup>+ <\/sup>+ 75% EGFR<sup>-<\/sup> cells = 2.5 ml EGFR<sup>+ <\/sup>+ 7.5 ml EGFR<sup>-<\/sup> cells<\/li>\n<\/ul>\n<\/li>\n<li>100% EGFR<sup>-<\/sup> cells = 10 ml EGFR<sup>-<\/sup> cells<\/li>\n<\/ul>\n<\/li>\n<li>Prepare BiTE\u00ae serial dilution plates (EGFR test BiTE\u00ae and CD33 positive control BiTE\u00ae for AML cell line)\n<ul>\n<li>22 dilutions + 1 column with target cells, T cells and no BiTE\u00ae and one column with target cells only)<\/li>\n<li>Starting 10X concentration is 10nM; serial dilutions in Assay Medium 2-fold across plate X 22 wells\n<ul>\n<li>Dispense 50 \u00b5l 10nM BiTE\u00ae into col. 1 and 25 \u00b5l Assay Medium into cols. 2-24<\/li>\n<li>Transfer 25 \u00b5l from col. 1 into col. 2, and so on across plate through col. 22)<\/li>\n<\/ul>\n<\/li>\n<li>Prepare T cells as described in TDCC protocol, except that cell density is 1x10e6 cells\/ml (1x10e6 cells\/ml X 0.025 ml = 25,000 cells\/well); 10 ml + dead volume needed per 384-well plate.<\/li>\n<li>Dispense 20 \u00b5l target cells and 25 \u00b5l T cells into assay plates (Multidrop); add 5 \u00b5l BiTE dilutions into assay plates (Bravo); mix 3 times with slow aspirate (Bravo).<\/li>\n<li>Leave assay plates at room temperature in hood for 30 min. before placing in tissue culture incubator.<\/li>\n<li>Incubate at 37\u00b0C for 48 hours.<\/li>\n<li>Steady-Glo\u00ae assay:\n<ul>\n<li>Thaw Steady-Glo\u00ae reagent to room temperature and reconstitute (10 ml needed per plate)<\/li>\n<li>Add 25 \u00b5l\/well of room temperature Steady-Glo\u00ae (Multidrop)<\/li>\n<li>Incubate 30 min. at room temperature<\/li>\n<li>Read on luminometer (EnVision with Ultrasensitive Lumi PMT)<\/li>\n<li>Analysis: Only EGFR<sup>-<\/sup> cells are labelled, so the luminescence readout is a direct count of EGFR<sup>-<\/sup> cytotoxicity<\/li>\n<\/ul>\n<\/li>\n<\/ul>\n<\/li>\n<\/ul>"},"is_project":0},{"component_id":"797305","previous_id":"797308","original_id":"0","guid":"D7BCAEC9EEDF433398D705A7ABA2D3AF","previous_guid":"D95412755C5948FAAAFE78EB647DA19A","component_type_id":"6","data_id":"0","data":"EGFR Bystander Steady- Glo\u00ae Luciferase TDCC Assay","order_id":"1","name":"Section","data_by_id":"0","type_id":"6","source_data":{"section":"EGFR Bystander Steady- Glo\u00ae Luciferase TDCC Assay"},"is_project":0}]},{"id":"493533","is_changed":"0","original_id":"0","is_skipped":"0","is_checked":"0","guid":"F0829D32880E4AB887164969D1C3BD10","previous_guid":"A0C04A9C640142CFB0FD9E58C484470E","previous_id":"493528","last_modified":"1494374384","components":[{"component_id":"797320","previous_id":0,"original_id":"0","guid":"B12AB1C5839C4F3FA87E646DB7C01185","previous_guid":null,"component_type_id":"1","data_id":"0","data":"<ul>\n<li>Overview: T cells are activated by incubating T cells (E:T = 10:1), EGFR BiTE\u00ae (100 pM) and EGFR<sup>+<\/sup> cells together in bulk for 24 hr. Control T cells are incubated with EGFR<sup>+<\/sup> cells but no EGFR BiTE\u00ae. T cells are then harvested, washed and resuspended for use in TDCC assays.<\/li>\n<li>Day 1: Plate target cells and prepare BiTE\u00ae-activated and control T cells\n<ul>\n<li>Plate EGFR+ (NUGC4) and EGFR- (SW620) cells in 96-well PackardView plates (for imaging) or Corning white plates (for CellTiter-Glo\u00ae) at 10,000 cells\/well\n<ul>\n<li>Cells can be pre-treated +\/- cytokines by replacing medium 8 hours after plating with Assay Medium containing IFN\u03b3 and\/or TNF\u03b1 at the desired concentrations (for upregulation of ICAM-1 and FAS, 10ng\/ml IFN\u03b3 + 5ng\/ml TNF\u03b1)<\/li>\n<li>Incubate overnight<\/li>\n<\/ul>\n<\/li>\n<li>Prepare BiTE\u00ae-activated and control T cells\n<ul>\n<li>Thaw frozen T cells as described in TDCC assay protocol<\/li>\n<li>Prepare EGFR BiTE\u00ae\n<ul>\n<li>Dilute stock to 2 nM (20X) in Assay Medium.<\/li>\n<\/ul>\n<\/li>\n<li>Prepare EGFR<sup>+<\/sup> NUGC4 target cells: Remove cells from flask with CellStripper\u2122 and resuspend at 0.33 x 10e6 cells\/ml (need at least 18 ml)\n<ul>\n<li>Transfer 3x10e6 cells (9 ml) to two 50 ml conical tubes (Tubes 1 and 2).<\/li>\n<\/ul>\n<\/li>\n<li>Prepare T cells\n<ul>\n<li>Dilute thawed T cells to 3x10e6\/ml in Assay Medium.<\/li>\n<\/ul>\n<\/li>\n<li>Activate T cells\n<ul>\n<li>To the tubes containing 3x10e6 cells (9 ml) target cells prepared above, add 1 ml 20X (2 nM) BiTE\u00ae to Tube 1 (100 pM final) and 1 ml Assay Medium to Tube 2 (0 pM final).<\/li>\n<li>Add 10 ml T cells at 3x10e6 cells\/ml (30x10e6 total) to each tube and mix gently.<\/li>\n<li>Transfer the contents of each tube (20 ml total) to separate T75 flasks\n<ul>\n<li>Flask 1 (from Tube 1) = BiTE\u00ae-activated T cells = target cells + 100 pM BiTE\u00ae + 30x10e6 T cells<\/li>\n<li>Flask 2 (from Tube 2) = 3x10e6 target cells without BiTE\u00ae + 30x10e6 T cells = control (resting) T cells<\/li>\n<\/ul>\n<\/li>\n<li>Incubate at 37\u00b0C for 24 hours.<\/li>\n<\/ul>\n<\/li>\n<li>Day 2: Harvest BiTE\u00ae-activated and control T cells and add to plated target cells\n<ul>\n<li>Harvest BiTE\u00ae-activated and control T cells\n<ul>\n<li>Collect T cells from each flask into two 50 ml conical tubes<\/li>\n<li>Wash cells\n<ul>\n<li>Centrifuge at 300 x g for 10 min.<\/li>\n<li>Remove supernatant and resuspend cell pellets in 20 ml fresh Assay Medium<\/li>\n<li>Centrifuge at 300 x g for 10 min.<\/li>\n<li>Remove supernatant and resuspend cell pellets in 10 ml fresh Assay Medium<\/li>\n<li>Count cells and dilute to 2x10e6\/ml<\/li>\n<\/ul>\n<\/li>\n<li>Remove medium from target cell plates (set-up on Day 1)\n<ul>\n<li>Add 50 \u00b5l Assay Medium or BiTE\u00ae at 2X in 50 \u00b5l Assay Medium to designated wells<\/li>\n<li>Add 50 \u00b5l BiTE\u00ae-activated or control T cells (100,000 cells) to designated wells<\/li>\n<\/ul>\n<\/li>\n<li>Incubate at 37\u00b0C for 24 hours.<\/li>\n<\/ul>\n<\/li>\n<li>Day 3: Assay cytotoxicity by imaging or CellTiter-Glo\u00ae as described in TDCC protocol.\n<ul>\n<li>Cyototoxicity assays can be multiplexed (see separate protocols):\n<ul>\n<li>T cell activation<\/li>\n<li>Soluble factors<\/li>\n<li>Immunofluorescence to test for expression of cell-associated markers, such as ICAM-1 and FAS<\/li>\n<\/ul>\n<\/li>\n<\/ul>\n<\/li>\n<\/ul>\n<\/li>\n<\/ul>\n<\/li>\n<\/ul>\n<\/li>\n<\/ul>","order_id":"0","name":"Description","data_by_id":"0","type_id":"1","source_data":{"description":"<ul>\n<li>Overview: T cells are activated by incubating T cells (E:T = 10:1), EGFR BiTE\u00ae (100 pM) and EGFR<sup>+<\/sup> cells together in bulk for 24 hr. Control T cells are incubated with EGFR<sup>+<\/sup> cells but no EGFR BiTE\u00ae. T cells are then harvested, washed and resuspended for use in TDCC assays.<\/li>\n<li>Day 1: Plate target cells and prepare BiTE\u00ae-activated and control T cells\n<ul>\n<li>Plate EGFR+ (NUGC4) and EGFR- (SW620) cells in 96-well PackardView plates (for imaging) or Corning white plates (for CellTiter-Glo\u00ae) at 10,000 cells\/well\n<ul>\n<li>Cells can be pre-treated +\/- cytokines by replacing medium 8 hours after plating with Assay Medium containing IFN\u03b3 and\/or TNF\u03b1 at the desired concentrations (for upregulation of ICAM-1 and FAS, 10ng\/ml IFN\u03b3 + 5ng\/ml TNF\u03b1)<\/li>\n<li>Incubate overnight<\/li>\n<\/ul>\n<\/li>\n<li>Prepare BiTE\u00ae-activated and control T cells\n<ul>\n<li>Thaw frozen T cells as described in TDCC assay protocol<\/li>\n<li>Prepare EGFR BiTE\u00ae\n<ul>\n<li>Dilute stock to 2 nM (20X) in Assay Medium.<\/li>\n<\/ul>\n<\/li>\n<li>Prepare EGFR<sup>+<\/sup> NUGC4 target cells: Remove cells from flask with CellStripper\u2122 and resuspend at 0.33 x 10e6 cells\/ml (need at least 18 ml)\n<ul>\n<li>Transfer 3x10e6 cells (9 ml) to two 50 ml conical tubes (Tubes 1 and 2).<\/li>\n<\/ul>\n<\/li>\n<li>Prepare T cells\n<ul>\n<li>Dilute thawed T cells to 3x10e6\/ml in Assay Medium.<\/li>\n<\/ul>\n<\/li>\n<li>Activate T cells\n<ul>\n<li>To the tubes containing 3x10e6 cells (9 ml) target cells prepared above, add 1 ml 20X (2 nM) BiTE\u00ae to Tube 1 (100 pM final) and 1 ml Assay Medium to Tube 2 (0 pM final).<\/li>\n<li>Add 10 ml T cells at 3x10e6 cells\/ml (30x10e6 total) to each tube and mix gently.<\/li>\n<li>Transfer the contents of each tube (20 ml total) to separate T75 flasks\n<ul>\n<li>Flask 1 (from Tube 1) = BiTE\u00ae-activated T cells = target cells + 100 pM BiTE\u00ae + 30x10e6 T cells<\/li>\n<li>Flask 2 (from Tube 2) = 3x10e6 target cells without BiTE\u00ae + 30x10e6 T cells = control (resting) T cells<\/li>\n<\/ul>\n<\/li>\n<li>Incubate at 37\u00b0C for 24 hours.<\/li>\n<\/ul>\n<\/li>\n<li>Day 2: Harvest BiTE\u00ae-activated and control T cells and add to plated target cells\n<ul>\n<li>Harvest BiTE\u00ae-activated and control T cells\n<ul>\n<li>Collect T cells from each flask into two 50 ml conical tubes<\/li>\n<li>Wash cells\n<ul>\n<li>Centrifuge at 300 x g for 10 min.<\/li>\n<li>Remove supernatant and resuspend cell pellets in 20 ml fresh Assay Medium<\/li>\n<li>Centrifuge at 300 x g for 10 min.<\/li>\n<li>Remove supernatant and resuspend cell pellets in 10 ml fresh Assay Medium<\/li>\n<li>Count cells and dilute to 2x10e6\/ml<\/li>\n<\/ul>\n<\/li>\n<li>Remove medium from target cell plates (set-up on Day 1)\n<ul>\n<li>Add 50 \u00b5l Assay Medium or BiTE\u00ae at 2X in 50 \u00b5l Assay Medium to designated wells<\/li>\n<li>Add 50 \u00b5l BiTE\u00ae-activated or control T cells (100,000 cells) to designated wells<\/li>\n<\/ul>\n<\/li>\n<li>Incubate at 37\u00b0C for 24 hours.<\/li>\n<\/ul>\n<\/li>\n<li>Day 3: Assay cytotoxicity by imaging or CellTiter-Glo\u00ae as described in TDCC protocol.\n<ul>\n<li>Cyototoxicity assays can be multiplexed (see separate protocols):\n<ul>\n<li>T cell activation<\/li>\n<li>Soluble factors<\/li>\n<li>Immunofluorescence to test for expression of cell-associated markers, such as ICAM-1 and FAS<\/li>\n<\/ul>\n<\/li>\n<\/ul>\n<\/li>\n<\/ul>\n<\/li>\n<\/ul>\n<\/li>\n<\/ul>\n<\/li>\n<\/ul>"},"is_project":0},{"component_id":"797312","previous_id":"797320","original_id":"0","guid":"FDEDAFA80DBC41F69FD8975A6202BD8F","previous_guid":"B12AB1C5839C4F3FA87E646DB7C01185","component_type_id":"6","data_id":"0","data":"TDCC assay using BiTE-activated T cells","order_id":"1","name":"Section","data_by_id":"0","type_id":"6","source_data":{"section":"TDCC assay using BiTE-activated T cells"},"is_project":0}]}]}